PHASE II TRIAL OF 4'-(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE (AMSA) IN THE TREATMENT OF ADVANCED NON-HODGKIN'S LYMPHOMAWARRELL RP JR; STRAUS DJ; YOUNG CW et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 10-11; PP. 1157-1158; BIBL. 6 REF.Article

CICATRICIAL ECTROPION SECONDARY TO 5-FLUOROURACIL THERAPY.STRAUS DJ; MAUSOLF FA; ELLERBY RA et al.1977; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1977; VOL. 3; NO 1; PP. 15-19; BIBL. 15 REF.Article

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY: CLINICAL SPECTRUM OF DISEASESCHAUER PK; STRAUS DJ; BAGLEY CM et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 11; PP. 2493-2498; BIBL. 38 REF.Article

TREATMENT OF ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA: AN ANALYSIS OF PROGNOSTIC VARIABLESKOZINER B; LITTLE C; PASSE S et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 8; PP. 1571-1579; BIBL. 26 REF.Article

COMBINATION CHEMOTHERAPY SALVAGE OF HEAVILY PRETREATED PATIENTS WITH HODGKIN'S DISEASE: AN ANALYSIS OF PROGNOSTIC FACTORS IN TWO CHEMOTHERAPY TRIALS AND THE LITERATURESTRAUS DJ; PASSE S; KOZINER B et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 207-211; BIBL. 12 REF.Article

EFFECTIVENESS OF METHYL-GAG (METHYLGLYOXAL-BIS (GUANYLHYDRAZONE)) IN PATIENTS WITH ADVANCED MALIGNANT LYMPHOMAWARRELL RP JR; LEE BJ; KEMPIN SJ et al.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 57; NO 6; PP. 1011-1014; BIBL. 22 REF.Article

THE TREATMENT OF ADVANCED HODGKIN'S DISEASESTRAUS DJ; LEE BJ; KOZINER B et al.1981; BLUT; ISSN 0006-5242; DEU; DA. 1981; VOL. 43; NO 2; PP. 119-124; BIBL. 10 REF.Article

CONCANAVALIN A-INDUCED SUPPRESSOR CELL ACTIVITY IN HODGKIN'S DISEASESCHULOF RS; LEE BJ; LACHER MJ et al.1980; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1980; VOL. 16; NO 4; PP. 454-462; BIBL. 21 REF.Article